LONGEVERON INC-A (LGVN) Fundamental Analysis & Valuation

NASDAQ:LGVNUS54303L2034

Current stock price

0.98 USD
-0.13 (-11.71%)
At close:
0.97 USD
-0.01 (-1.02%)
After Hours:

This LGVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. LGVN Profitability Analysis

1.1 Basic Checks

  • LGVN had negative earnings in the past year.
  • In the past year LGVN has reported a negative cash flow from operations.
  • LGVN had negative earnings in each of the past 5 years.
  • In the past 5 years LGVN always reported negative operating cash flow.
LGVN Yearly Net Income VS EBIT VS OCF VS FCFLGVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • LGVN has a Return On Assets of -137.18%. This is amonst the worse of the industry: LGVN underperforms 82.53% of its industry peers.
  • LGVN's Return On Equity of -214.14% is on the low side compared to the rest of the industry. LGVN is outperformed by 69.87% of its industry peers.
Industry RankSector Rank
ROA -137.18%
ROE -214.14%
ROIC N/A
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
LGVN Yearly ROA, ROE, ROICLGVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • LGVN's Gross Margin of 74.88% is amongst the best of the industry. LGVN outperforms 83.30% of its industry peers.
  • In the last couple of years the Gross Margin of LGVN has grown nicely.
  • LGVN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
LGVN Yearly Profit, Operating, Gross MarginsLGVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

5

2. LGVN Health Analysis

2.1 Basic Checks

  • LGVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LGVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LGVN Yearly Shares OutstandingLGVN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
LGVN Yearly Total Debt VS Total AssetsLGVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • LGVN has an Altman-Z score of -12.53. This is a bad value and indicates that LGVN is not financially healthy and even has some risk of bankruptcy.
  • LGVN has a Altman-Z score of -12.53. This is in the lower half of the industry: LGVN underperforms 77.74% of its industry peers.
  • LGVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.53
ROIC/WACCN/A
WACC9.03%
LGVN Yearly LT Debt VS Equity VS FCFLGVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.09 indicates that LGVN has no problem at all paying its short term obligations.
  • LGVN's Current ratio of 2.09 is on the low side compared to the rest of the industry. LGVN is outperformed by 75.24% of its industry peers.
  • LGVN has a Quick Ratio of 2.09. This indicates that LGVN is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.09, LGVN is not doing good in the industry: 73.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
LGVN Yearly Current Assets VS Current LiabilitesLGVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

3

3. LGVN Growth Analysis

3.1 Past

  • LGVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.60%, which is quite impressive.
EPS 1Y (TTM)69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.64%

3.2 Future

  • The Earnings Per Share is expected to decrease by -14.67% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 243.64% on average over the next years. This is a very strong growth
EPS Next Y-4.79%
EPS Next 2Y-14.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.83%
Revenue Next 2Y236.46%
Revenue Next 3Y243.64%
Revenue Next 5YN/A

3.3 Evolution

LGVN Yearly Revenue VS EstimatesLGVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
LGVN Yearly EPS VS EstimatesLGVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

0

4. LGVN Valuation Analysis

4.1 Price/Earnings Ratio

  • LGVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year LGVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGVN Price Earnings VS Forward Price EarningsLGVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGVN Per share dataLGVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

  • A cheap valuation may be justified as LGVN's earnings are expected to decrease with -14.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.67%
EPS Next 3YN/A

0

5. LGVN Dividend Analysis

5.1 Amount

  • No dividends for LGVN!.
Industry RankSector Rank
Dividend Yield 0%

LGVN Fundamentals: All Metrics, Ratios and Statistics

LONGEVERON INC-A

NASDAQ:LGVN (3/20/2026, 8:05:57 PM)

After market: 0.97 -0.01 (-1.02%)

0.98

-0.13 (-11.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17
Earnings (Next)N/A
Inst Owners8.57%
Inst Owner Change-2.04%
Ins Owners8.61%
Ins Owner Change-0.79%
Market Cap28.69M
Revenue(TTM)N/A
Net Income(TTM)-21.34M
Analysts82.5
Price Target7 (614.29%)
Short Float %8.47%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.86%
Min EPS beat(2)-49.94%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-16.87%
Min EPS beat(4)-49.94%
Max EPS beat(4)8.22%
EPS beat(8)3
Avg EPS beat(8)-18.04%
EPS beat(12)3
Avg EPS beat(12)-16.17%
EPS beat(16)5
Avg EPS beat(16)-11.14%
Revenue beat(2)0
Avg Revenue beat(2)-39.57%
Min Revenue beat(2)-52.82%
Max Revenue beat(2)-26.32%
Revenue beat(4)0
Avg Revenue beat(4)-31.04%
Min Revenue beat(4)-52.82%
Max Revenue beat(4)-7.27%
Revenue beat(8)2
Avg Revenue beat(8)140.83%
Revenue beat(12)2
Avg Revenue beat(12)81.18%
Revenue beat(16)5
Avg Revenue beat(16)72.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-8.26%
Revenue NQ rev (3m)-8.26%
Revenue NY rev (1m)-11.84%
Revenue NY rev (3m)-11.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.97
P/FCF N/A
P/OCF N/A
P/B 2.88
P/tB 3.75
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-1.34
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.05
BVpS0.34
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -137.18%
ROE -214.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.88%
FCFM N/A
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.96%
Cap/Sales 45.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z -12.53
F-Score4
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)90.92%
Cap/Depr(5y)89.88%
Cap/Sales(3y)69.8%
Cap/Sales(5y)62.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
EPS Next Y-4.79%
EPS Next 2Y-14.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.64%
Revenue Next Year-11.83%
Revenue Next 2Y236.46%
Revenue Next 3Y243.64%
Revenue Next 5YN/A
EBIT growth 1Y-25.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.41%
OCF growth 3YN/A
OCF growth 5YN/A

LONGEVERON INC-A / LGVN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LONGEVERON INC-A (LGVN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LGVN.


Can you provide the valuation status for LONGEVERON INC-A?

ChartMill assigns a valuation rating of 0 / 10 to LONGEVERON INC-A (LGVN). This can be considered as Overvalued.


How profitable is LONGEVERON INC-A (LGVN) stock?

LONGEVERON INC-A (LGVN) has a profitability rating of 1 / 10.


How financially healthy is LONGEVERON INC-A?

The financial health rating of LONGEVERON INC-A (LGVN) is 5 / 10.